Document is current
Any future updates will be listed below
-
Authors
Sarangdhar, Mayuresh
Akel, Sarah
Hosseini Ashtiani, Saman
Axelsson, Markus
Zelano, Johan
-
Funding
Funding for this research was provided by:
Wallenberg Center for Molecular and Translational Medicine
Jeansson foundation (JS2014-0032)
Swedish Society for Medical Research (SS18-0040)
Region Västra Götaland (VGFOUREG-968476)
ALF- agreement (ALFGBG-715781)
Wilhelm & Martina Lundgrens Vetenskapsfond
Hjärnfonden
Ann-Louise och Sven-Erik Beiglers foundation
Amlöv foundation
University of Gothenburg
- License Information
-
More Information
Article History
Received: 7 April 2025
Accepted: 2 October 2025
First Online: 13 October 2025
Declarations
:
: The study was approved by the Swedish Ethical Review Authority (approval number 2020–00853). All participants provided written informed consent prior to inclusion.
: Not applicable.
: J.Z. has received speaker honoraria from UCB and Eisai for non-branded educations; and as an employee of Sahlgrenska University Hospital is or has been an investigator/sub investigator in clinical trials sponsored by GW Pharma, SK life science, UCB, Angilini Pharma, and Bial (no personal compensation). M.A. has received compensation for lectures and/or advisory boards from Biogen, Genzyme, and Novartis. The remaining authors report no conflicts of interest.
